Skip to menu Skip to content Skip to footer

2009

Journal Article

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

Al-badriyeh, Daoud, Liew, Danny, Stewart, Kay and Kong, David C.M. (2009). Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. Journal of Antimicrobial Chemotherapy, 63 (1), 197-208. doi: 10.1093/jac/dkn459

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

2006

Journal Article

A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.

Liew, Danny A., Lim, Stephen S., Bertram, Melanie, McNeil, John J. and Vos, Theo (2006). A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.. European Journal of Cardiovascular Prevention and Rehabilitation, 13 (4), 515-522. doi: 10.1097/01.hjr.0000224488.03221.97

A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.

2005

Journal Article

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70

Nelson, Mark R., Liew, Danny, Bertram, Melanie and Vos, Theo (2005). Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70. British Medical Journal, 330 (7503), 1306-1308A. doi: 10.1136/bmj.38456.676806.8F

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70

2003

Journal Article

Eplerenone (Pharmacia)

Liew, Danny, Martin, Jennifer and Krum, Henry (2003). Eplerenone (Pharmacia). Current Opinion in Investigational Drugs, 4 (3), 316-322.

Eplerenone (Pharmacia)

2003

Journal Article

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply

Liew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2003). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply. Medical Journal of Australia, 178 (4), 188-189.

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply

2002

Journal Article

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

Liew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2002). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Medical Journal of Australia, 177 (7), 364-367.

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2001

Journal Article

Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria

Lim, Stephen S., Vos, Theo, Peeters, Anna, Liew, Danny and McNeil, John J. (2001). Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria. Medical Journal of Australia, 175 (9), 459-464. doi: 10.5694/j.1326-5377.2001.tb143676.x

Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria

2001

Journal Article

A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk

McNeil, J. J., Peeters, A., Liew, D., Lim, S. and Vos, T. (2001). A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. Journal of Cardiovascular Risk, 8 (1), 31-37. doi: 10.1097/00043798-200102000-00005

A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk